RxDoctor Payments Data

Alice Mathews

Family · Marietta, GANPI 1467869503

Payments from drug & device makers

$809in general payments, 2019–2025

Across 32 payments — averaging $25.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$190
  • 180 Medical, Inc.$135
  • Medtronic$131
  • Astellas Pharma US Inc$85
  • Boston Scientific$49
  • Myovant Sciences Inc.$48
  • plus $170 from 7 others

What the payments were for

  • Food & beverage$809100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$809 in reported general payments places this provider in the 60th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$37,651
Medicare patients
179
Services billed
1,912

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron73$61,483
GemtesaVibegron16$10,283
Tamsulosin Hcl314$4,223
Methenamine Hippurate20$1,757
Solifenacin Succinate14$1,718
Estradiol25$1,713
Finasteride127$1,551
Trospium Chloride18$1,197
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst55$1,146
Trospium Chloride ErTrospium Chloride15$953
Dutasteride15$460
CefuroximeCefuroxime Axetil30$376
Oxybutynin Chloride ErOxybutynin Chloride29$362
Alfuzosin Hcl ErAlfuzosin Hcl23$278
Oxybutynin Chloride23$277

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$85$61,48373 claims
Sumitomo Pharma America, Inc.Gemtesa$190$10,28316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,258 family providers in Georgia.

Other family in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →